Calif. Cipro Purchasers Seek Approval Of Settlement With Bayer Over Pay-For-Delay

Calif. Cipro Purchasers Seek Approval Of Settlement With Bayer Over Pay-For-Delay

SAN DIEGO - California purchasers of the antibiotic Cipro and third-party payers who reimbursed for California purchases of Cipro on July 11 asked a state court to grant preliminary approval to their $74 million cash settlement with Bayer Corp. and Bayer AG (collectively, Bayer) on claims that Bayer paid drug companies nearly $400 million to drop challenges to Bayer's Cipro patent and to refrain from selling generic versions of the drug (CIPRO Cases I and II $(All Actions$), Judicial Council Coordination Proceeding Nos. 4154 and 4220, Calif. Super., San Diego Co.).

Find full version on lexis Advance®
Access this news story on lexis.com®